HOWL - Werewolf Therapeutics GAAP EPS of -$0.14 beats by $0.27 revenue of $8.08M beats by $4.93M August, 10 2023 10:32 AM Werewolf Therapeutics Inc. 2023-08-10 10:32:34 ET Werewolf Therapeutics press release ( NASDAQ: HOWL ): Q2 GAAP EPS of -$0.14 beats by $0.27 . Revenue of $8.08M (+94.7% Y/Y) beats by $4.93M . For further details see: Werewolf Therapeutics GAAP EPS of -$0.14 beats by $0.27, revenue of $8.08M beats by $4.93M